As a manager overseeing research or testing laboratories, you will encounter various planned and unforeseen events necessitating the exploration of alternative staffing solutions. Both short-term fluctuations in testing volume, staffing shortages, skill gaps, and equipment downtime, as well as long-term considerations, can prompt the need to identify an outsourcing partner lab that aligns with your requirements and budget. Achieving a successful partnership involves refining your specific support requirements, selecting suitable providers, and effectively managing the collaboration.

Unbiosta Broker Website
Unbiosta Broker Website

Who we are

Unbiosta Broker is a diagnostic solution provider company founded in 2019 by a group of highly experienced professionals with over 15 years of expertise in the diagnostics and biological testing field.
Unbiosta Broker is a provider of complete and innovative solution in terms of biological diagnostics, from clinical research to local and hyper-specialised medical biology, through his lab partners who are the European leaders in specialised medical biology. 

Our Mission

Unbiosta Broker can bring you a wide range of expertise to support all the players in the healthcare chain, including healthcare professionals, the pharmaceutical and diagnostics industries, and medical laboratories, helping to shape the medicine of tomorrow.
With more than 3,000 tests available, Unbiosta Broker has built its reputation thorough its partners on the continuous development of new tests and the performance of analyses with high medical added value. As a partner of first-line medical analysis laboratories, Unbiosta Broker Diagnostics puts its cutting-edge expertise to work every day for local medical biology laboratories and hospital technical platforms. Day after day, Unbiosta business development team contribute to bring onboard to you a better prevention, ever earlier screening, finer and faster diagnosis.
Unbiosta Broker Website
A wide range of expertise

to support all the players in the healthcare chain, including healthcare professionals, the pharmaceutical and diagnostics industries, and medical laboratories, helping to shape the medicine of tomorrow.

Unbiosta Broker Website
Business development

Day after day, Unbiosta business development team contribute to bring onboard a better prevention, ever earlier screening, finer and faster diagnosis.

UNBIOSTA Broker Website
More than 3,000 tests available

The continuous development of new tests and the performance of analyses with high medical added value. As a partner of first-line medical analysis laboratories.

Unbiosta Broker commitment

Supporting public and Private health care
With nearly 50,000 medical diagnostic tests performed every day at our partner labs who are committed to ensuring that every patient, wherever they are, has access to the most specialised and innovative techniques for screening, diagnosis, monitoring and adjusting therapies.
Unbiosta Broker daily collection network guarantee continuity of care throughout the country and internationally. Unbiosta Broker is committed to guaranteeing the same level of care, the same quality and the same access to innovation throughout Europe, for the greater benefit of patients and the medical profession. 

Unbiosta Broker in numbers

UNBIOSTA Broker Website

50 Lab partners in Europe

Unbiosta Broker has helped more than 40 countries to outsource their testing to the most experimented and specialised labs in Europe.
UNBIOSTA Broker Website

50,000 essays per day

Unbiosta Broker and its experimented and accredited lab partners has helped to realise more than 50,000 analyses per day of a specialised tests.

UNBIOSTA Broker Website

The largest testing menu

Our partnership with multiple labs has given us the opportunity to offer the largest testing menu and the most competitive pricing and Turnaround time (TAT) in Europe.

N I P T

Non-Invasive Prenatal Testing for trisomies 21, 18 and 13 (NIPT)
The prenatal trisomy screening test based on a simple maternal blood sample
What is the NIPT screening test?
Non-invasive Prenatal Testing (NIPT) is an innovative genetic screening test for chromosomal abnormalities.
This test uses circulating cell-free DNA (cfDNA) from a maternal blood sample without risk to the fetus.
NIPT detects the main fœtal aneuploidies i.e. trisomy 21, 18 and 13. They’re the only ones complete and homogenous trisomies found at birth outside of the dysgonosomias.
This test uses next-generation sequencing (NGS) and is performed after the 1st trimester ultrasound.

Today, this test also makes it possible to screen for other rarer chromosome abnormalities : autosomal abnormalities, deletion and duplication greater than 7 megabases (karyotype-equivalent resolution)

Unbiosta Broker Website
NIPT 3

Non-Invasive Prenatal Testing for trisomies 21, 18 and 13 (NIPT).

Unbiosta Broker Website
NIPT 5

Non-Invasive Prenatal Testing for trisomies 21, 18 and 13 (NIPT))
+ Fetal gender determination
+ Sex chromosomes aneuploidies

UNBIOSTA Broker Website
NIPT Genome Wide

All autosomes
+ chromosomal imbalance greater than 7Mb

UNBIOSTA Broker Website
NIPT Genome Wide

All autosomes
+ chromosomal imbalance greater than 7Mb

Our Partners

bio company, laboratories, ipo

Contact us

Contacts

Get in touch
  • Email: broker@unbiosta.com

  • Address:
  • Street Central Business District
  • Zone 1,
  • Zip CBD 1070,
  • Birkirkara,
  • Malta